Oncology
antibodies

Antibody drug conjugates – The time is now

The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs ca

News
Dr Kristina Lang

AI shows its value in mammography screening

A study has shown that artificial intelligence can be safely used to support mammography to spot breast cancers and may spot more tumours than the current standard approac

News
Dr Kristina Lang

AI shows its value in mammography screening

A study has shown that artificial intelligence can be safely used to support mammography to spot breast cancers and may spot more tumours than the current standard approac

News

News
Dr Kristina Lang

AI shows its value in mammography screening

A study has shown that artificial intelligence can be safely used to support mammography to spot breast cancers and may spot more tumours than the current standard approac

Views & Analysis

Oncology
antibodies

Antibody drug conjugates – The time is now

The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs ca

Deep Dive

Oncology
Oncology 2023

Oncology 2023

Few areas in healthcare can unite stakeholders across industry, political leanings, and social status, quite like cancer.

Newsletters and Deep Dive
digital magazine

Webinars

on demand
Oncology
Print
Sponsored

Clinical decision-making insights for haem/oncs

Despite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several decision-making challenges for healthcare professionals.

Podcasts

Video

Oncology
ASCO 2023 – Dr Lalan Wilfong

ASCO 2023 – Dr Lalan Wilfong

In the last video from ASCO 2023, we step away from the R&D side to talk about drug costs and payment models.

Oncology
ASCO 2023 Jaydev Thakkar

ASCO 2023 – Jaydev Thakkar

In our penultimate video from ASCO 2023, editor-in-chief Jonah Comstock touches base with Biofourmis chief operating officer Jaydev Thakkar.

Oncology
ASCO 2023 Mark Reisenauer

ASCO 2023 – Mark Reisenauer

As we approach the last of our exclusive coverage of ASCO 2023, editor-in-chief Jonah Comstock speaks with Mark Reisenauer, president of US commercial at Astellas.

White Papers

Debates & Insight

Partner Content

Oncology
mRNA Cancer Vaccine Summit 2023
Partner Content

mRNA Cancer Vaccine Summit 2023

The mRNA Cancer Vaccine Summit 2023 comes to Boston as the community is on the cusp of something truly exciting.

Oncology
8th CAR-TCR Summit
Partner Content

8th CAR-TCR Summit

The 8th CAR-TCR Summit is returning to Boston as the industry’s trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug develope